333 related articles for article (PubMed ID: 9177196)
1. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
[TBL] [Abstract][Full Text] [Related]
3. Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin.
Popescu CI; Paduraru C; Dwek RA; Petrescu SM
J Biol Chem; 2005 Apr; 280(14):13833-40. PubMed ID: 15677452
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
Svedine S; Wang T; Halaban R; Hebert DN
J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase maturation and oligomerization in the endoplasmic reticulum require a melanocyte-specific factor.
Francis E; Wang N; Parag H; Halaban R; Hebert DN
J Biol Chem; 2003 Jul; 278(28):25607-17. PubMed ID: 12724309
[TBL] [Abstract][Full Text] [Related]
6. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
7. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
[TBL] [Abstract][Full Text] [Related]
8. Cellular localization of tyrosinase in human malignant melanoma cell lines.
Foa C; Aubert C
J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
Toyofuku K; Wada I; Spritz RA; Hearing VJ
Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
[TBL] [Abstract][Full Text] [Related]
10. Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands.
Le Gros G; Zhang XM; Parsons PG
Melanoma Res; 1994 Dec; 4(6):359-64. PubMed ID: 7535606
[TBL] [Abstract][Full Text] [Related]
11. Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase.
Wang Y; Androlewicz MJ
Biochem Biophys Res Commun; 2000 Apr; 271(1):22-7. PubMed ID: 10777675
[TBL] [Abstract][Full Text] [Related]
12. Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway.
Halaban R; Patton RS; Cheng E; Svedine S; Trombetta ES; Wahl ML; Ariyan S; Hebert DN
J Biol Chem; 2002 Apr; 277(17):14821-8. PubMed ID: 11812790
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of tyrosinase inhibitors and their differential action on melanogenic subcellular compartments in amelanotic and melanomas.
Imokawa G; Mishima Y
Br J Dermatol; 1980 Dec; 103(6):625-33. PubMed ID: 6779849
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells.
Negroiu G; Dwek RA; Petrescu SM
J Biol Chem; 2003 Jul; 278(29):27035-42. PubMed ID: 12719423
[TBL] [Abstract][Full Text] [Related]
16. [Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome].
Xu W; Lin FQ; Liu JF; Fu LF; Hong WS; Zhou MN; Xu AE; Guan CP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):123-7. PubMed ID: 23648349
[TBL] [Abstract][Full Text] [Related]
17. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
Imokawa G; Mishima Y
Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the cytosolic and melanosome-bound tyrosinase activities in Harding-Passey mouse melanoma.
García-Borrón JC; Martinez JH; Arocas A; Solano F; Vicente V; Gómez S; Iborra JL; Lozano JA
Int J Biochem; 1985; 17(9):995-1002. PubMed ID: 3934011
[TBL] [Abstract][Full Text] [Related]
19. Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine.
Halaban R; Cheng E; Svedine S; Aron R; Hebert DN
J Biol Chem; 2001 Apr; 276(15):11933-8. PubMed ID: 11124258
[TBL] [Abstract][Full Text] [Related]
20. Promotion of tyrosinase folding in COS 7 cells by calnexin.
Toyofuku K; Wada I; Hirosaki K; Park JS; Hori Y; Jimbow K
J Biochem; 1999 Jan; 125(1):82-9. PubMed ID: 9880801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
